Pulmonary biomarkers in asthma and COPD

P. Montuschi (Rome, Italy)

Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Session: PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Session type: Postgraduate Course
Number: 142
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Montuschi (Rome, Italy). Pulmonary biomarkers in asthma and COPD. Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004

Cardiac biomarkers and outcomes of COPD exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

COPD and other pulmonary diseases
Source: Eur Respir Monogr 2015; 67: 161-178
Year: 2015


Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Exacerbations of asthma and COPD
Source: ERS Skills Course 2016
Year: 2016

Exacerbations of asthma and COPD
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Exacerbations of asthma and COPD
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Pulmonary rehabilitation and exacerbations of COPD
Source: Eur Respir Monogr 2021; 93: 165-181
Year: 2021


Pulmonary vascular remodelling in COPD versus bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003

Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Pulmonary functional diagnosis of COPD
Source: Virtual Congress 2020 – Russian speaking programme 2020: Part I
Year: 2020


Asthma and smoking-induced airway disease without spirometric COPD
Source: Eur Respir J, 49 (5) 1602061; 10.1183/13993003.02061-2016
Year: 2017



Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013

Blood biomarkers in asthma and COPD
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


Lung hyperinflation in COPD and asthma
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010


Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Relationship of cardiac biomarkers in COPD to exacerbation and hyperinflation
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

COPD
Source: ERS Skills Course 2016
Year: 2016